In today's Just The Facts..
International Graphite has settled the land purchase for Australia’s first commercial graphite micronising facility in Collie, WA—moving one step closer to construction and production scale-up.
Recce Pharmaceuticals has secured a key Hong Kong patent, covering its anti-infectives R327 and R529. The grant extends protection to 2041 and supports multiple treatment delivery methods.
Altech Batteries has finalised engineering on its Sodium Nickel Chloride UPS system, with testing set for March 2026. The rollout will target five Dutch sites, replacing legacy battery systems with solid-state units.
Race Oncology has received a $2.79 million R&D tax refund from the ATO for FY2025. It comes under Australia’s R&D Incentive Program, offering rebates of up to 43.5% on eligible innovations. It's also secured a binding advance finding for up to $20.08 million in overseas R&D rebates through 2026.
#ASXNews #ProactiveInvestors #BatteryMaterials #AntibioticResistance #CriticalMinerals #SolidStateBattery #MedicalResearch